ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
맞춤형 유전체학 시장 규모는 향후 몇 년간 급성장할 것으로 예측됩니다. 향후 성장에 기여하는 요인으로는 맞춤형 치료에 대한 관심 증가, 소비자 직접 검사(DTC)의 보급 확대, 예방 의료 모델의 중시 증가, 유전체 데이터베이스 및 계산 툴 액세스의 향상, 제약기업과 유전체 관련 기업과의 제휴 강화 등을 들 수 있습니다. 다가오는 주요 트렌드로는 차세대 시퀀싱(NGS) 방법의 발전, 유전체 정보 해독을 위한 AI 사용, 유전체 데이터와 전자의무기록의 병합, 생물정보학 기술의 진화, 유전체 데이터 저장 및 교환을 위한 클라우드 기반 플랫폼의 확장 등이 있습니다.
만성질환과 희소질환 증가는 맞춤형 유전체학 시장의 성장을 가속할 것으로 예측됩니다. 건강에 해로운 식생활, 운동 부족, 환경 위험에 대한 노출과 같은 라이프 스타일 요인이 이러한 질병 증가에 크게 기여하고 있습니다. 개인 맞춤형 유전체학은 개인의 유전자 프로필에 맞게 치료법을 조정하여 보다 정확한 진단, 표적 치료, 병리학의 개선을 가능하게 하고 만성 질환 및 희귀질환의 관리에 중요한 역할을 하고 있습니다. 2023년 1월에 국립생명공학정보센터는 최소 하나의 만성 질환을 앓고 있는 사람들의 수가 2020년 7,152만 2,000명에서 2050년에는 1억 4,266만 명으로 99.5% 증가할 것으로 예측하고 있다고 밝혔습니다.
맞춤형 유전체학 시장의 주요 기업은 건강, 웰빙 및 질병 예방에 대한 개별화 된 통찰력을 제공하기 위해 맞춤형 유전체학 플랫폼을 포함한 혁신적인 기술 개발에 주력하고 있습니다. 맞춤형 유전체학 플랫폼은 사람의 유전자 정보를 분석하고 맞춤형 건강, 영양 및 치료 권장 사항을 제공하도록 설계되었습니다. Neuberg Diagnostics Private Limited는 맞춤형 유전체학 플랫폼인 Geniee Decode Your DNA를 출시했습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 맞춤형 유전체학 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 맞춤형 유전체학 시장 : 성장률 분석
세계의 맞춤형 유전체학 시장 실적: 규모와 성장, 2019-2024년
세계의 맞춤형 유전체학 시장 예측 : 규모와 성장, 2024-2029년, 2034년
세계의 맞춤형 유전체학 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 맞춤형 유전체학 시장 : 검사 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
종양학 검사
감염증 검사
신경학적 검사
심혈관 검사
기타 검사 유형
세계의 맞춤형 유전체학 시장 : 기술별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
중합효소 연쇄반응에 의한 검사
마이크로어레이 기반 검사
시퀀싱 기반 검사
기타
세계의 맞춤형 유전체학 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
진단
정밀의료
웰빙
생식보건
스포츠 영양과 건강
라이프 스타일
기타
세계의 맞춤형 유전체학 시장 : 최종 사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
병원 및 클리닉
연구센터
제약 및 생명 공학 기업
진단 실험실
기타
세계의 맞춤형 유전체학 시장 : 종양학 검사 세분화(검사 유형별), 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
액체 생검
종양 프로파일링
암 위험의 유전자 검사
동반진단
세계의 맞춤형 유전체학 시장 : 감염증 검사 세분화(검사 유형별), 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
간염 검사
COVID-19 검사
호흡기 감염증 검사
성감염증 검사
세계의 맞춤형 유전체학 시장 : 신경학적 검사 세분화, 검사 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
알츠하이머병 검사
헌팅턴병 검사
파킨슨병 검사
간질검사
세계의 맞춤형 유전체학 시장 : 심혈관 검사 세분화(검사 유형별), 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
심혈관 질환의 유전적 위험
부정맥 검사
지질 패널 검사
관상 동맥 질환 검사
세계의 맞춤형 유전체학 시장 : 기타 검사 유형의 세분화, 검사 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
약리 유전체학 검사
유전성 질환의 유전자 검사
부자 감정
조상검사
제7장 지역별/국가별 분석
세계의 맞춤형 유전체학 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
세계의 맞춤형 유전체학 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
맞춤형 유전체학 시장 : 경쟁 구도
맞춤형 유전체학 시장 : 기업 프로파일
Thermo Fisher Scientific Inc.
Illumina Inc.
Myriad Genetics Inc.
BGI Genomics Co. Ltd.
Invitae Corporation
제31장 기타 주요 기업 및 혁신 기업
Guardant Health Inc.
GeneDx LLC
Ancestry Inc.
Oxford Nanopore Technologies plc
Genomic Health Inc.
23andMe Holding Co.
Color Health Inc.
Helix OpCo LLC
Personalis Inc.
Dante Genomics
Gene By Gene Ltd.
Veritas Genetics Inc.
Futura Genetics
Nebula Genomics Inc.
Pathway Genomics Corporation
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 전략
맞춤형 유전체학 시장, 2029년 : 새로운 기회를 제공하는 국가
맞춤형 유전체학 시장, 2029년 : 새로운 기회를 제공하는 부문
맞춤형 유전체학 시장, 2029년 : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
SHW
영문 목차
영문목차
Personalized genomics refers to the application of an individual's genetic data to customize healthcare, lifestyle guidance, or risk evaluations for diseases, all based on their distinct DNA makeup. It is utilized in areas such as forecasting disease risks, enhancing drug efficacy, and shaping proactive health strategies.
The primary test categories within personalized genomics include oncology testing, infectious disease testing, neurological testing, cardiovascular testing, and various other diagnostic types. Oncology testing encompasses procedures for identifying, diagnosing, and tracking cancer progression through genetic, molecular, and imaging techniques. Methods used in oncology testing comprise polymerase chain reaction (PCR)-based diagnostics, microarray-based analyses, sequencing-based evaluations, and other cutting-edge technologies. These tools support use cases like diagnostics, precision medicine, reproductive health, wellness, sports nutrition, and lifestyle optimization, serving entities such as hospitals, clinics, research bodies, pharmaceutical and biotech firms, diagnostic labs, and more.
The personalized genomics market research report is one of a collection of recent publications from The Business Research Company that delivers comprehensive insights into market statistics for personalized genomics, including global market value, regional distribution, competitive landscape, detailed segmentation, current trends, opportunities, and all other information necessary for success in the industry. This report presents a thorough examination of both present conditions and future projections in the personalized genomics market.
The personalized genomics market size has grown rapidly in recent years. It will grow from $8.15 billion in 2024 to $9.45 billion in 2025 at a compound annual growth rate (CAGR) of 16.0%. The historical growth can be linked to increased public awareness of genetic health risks, a surge in chronic and hereditary diseases, enhanced use of AI and machine learning in genomics, a rising interest in lifestyle and nutrition-related genomics, and an expanding role of companion diagnostics in oncology and rare conditions.
The personalized genomics market size is expected to see rapid growth in the next few years. It will grow to $16.97 billion in 2029 at a compound annual growth rate (CAGR) of 15.8%. Factors contributing to future growth include heightened interest in tailored medical treatments, expanding popularity of direct-to-consumer (DTC) genetic tests, growing emphasis on preventive care models, increased accessibility to genomic databases and computational tools, and strengthened partnerships between pharmaceutical companies and genomic firms. Key upcoming trends include progress in next-generation sequencing (NGS) methods, the use of AI for decoding genomic information, merging of genomic data with electronic medical records, evolution of bioinformatics technologies, and expansion of cloud-based platforms for genomic data storage and exchange.
The increasing prevalence of chronic and rare diseases is anticipated to drive the growth of the personalized genomics market. Chronic diseases are long-term conditions that require continuous care, while rare diseases are infrequent and often demand specialized medical attention. Lifestyle factors such as unhealthy diets, physical inactivity, and exposure to environmental risks contribute significantly to the rise of these diseases. Personalized genomics plays a crucial role in managing chronic and rare diseases by tailoring treatments to an individual's genetic profile, enabling more accurate diagnoses, targeted therapies, and improved condition management. For example, in January 2023, the National Center for Biotechnology Information reported that the number of people with at least one chronic disease is projected to rise by 99.5%, from 71.522 million in 2020 to 142.66 million by 2050. As a result, the increasing burden of chronic and rare diseases is contributing to the expansion of the personalized genomics market.
Leading companies in the personalized genomics market are focusing on the development of innovative technologies, including personalized genomics platforms, to offer individualized insights into health, wellness, and disease prevention. A personalized genomics platform is designed to analyze a person's genetic information to provide customized health, nutrition, and treatment recommendations. For instance, in September 2024, Neuberg Diagnostics Private Limited, an India-based diagnostics company, launched Geniee Decode Your DNA, a personalized genomics platform. This platform delivers genetic-based insights that help optimize health, prevent disease, and customize treatments for better health outcomes.
In February 2022, Labcorp Holdings Inc., a U.S.-based life sciences company, acquired Personal Genome Diagnostics Inc. to strengthen its oncology offerings. The acquisition is intended to broaden access to advanced genomic profiling and liquid biopsy technologies, improving the diagnosis and treatment of cancer through personalized methods. Personal Genome Diagnostics Inc. is a U.S.-based cancer genomics company that focuses on identifying tumor biomarkers to personalize cancer therapies.
Major players in the personalized genomics market are Thermo Fisher Scientific Inc., Illumina Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, Guardant Health Inc., GeneDx LLC, Ancestry Inc., Oxford Nanopore Technologies plc, Genomic Health Inc., 23andMe Holding Co., Color Health Inc., Helix OpCo LLC, Personalis Inc., Dante Genomics, Gene By Gene Ltd., Veritas Genetics Inc., Futura Genetics, Nebula Genomics Inc., and Pathway Genomics Corporation.
North America was the largest region in the personalized genomics market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in personalized genomics report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the personalized genomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The personalized genomics market consists of revenues earned by entities by providing services such as pharmacogenomic services, genetic counseling, and customized fitness plans. The market value includes the value of related goods sold by the service provider or included within the service offering. The personalized genomics market also includes sales of genetic testing kits, health risk assessments, and nutrigenomics. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Personalized Genomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on personalized genomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for personalized genomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The personalized genomics market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Test Type: Oncology Testing; Infectious Disease Testing; Neurological Testing; Cardiovascular Testing; Other Test Types
2) By Technology: Polymerase Chain Reaction-Based Tests; Microarray-Based Tests; Sequencing-Based Tests; Other Technologies
3) By Application: Diagnostics; Precision Medicine; Wellness; Reproductive Health; Sports Nutrition And Health; Lifestyle; Other Applications
4) By End User: Hospitals And Clinics; Research Centers; Pharmaceutical And Biotechnology Companies; Diagnostic Laboratories; Other End Users
Subsegments:
1) By Oncology Testing: Liquid Biopsy; Tumor Profiling; Genetic Testing For Cancer Risk; Companion Diagnostics
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Personalized Genomics Market Characteristics
3. Personalized Genomics Market Trends And Strategies
4. Personalized Genomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Personalized Genomics Growth Analysis And Strategic Analysis Framework
5.1. Global Personalized Genomics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Personalized Genomics Market Growth Rate Analysis
5.4. Global Personalized Genomics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Personalized Genomics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Personalized Genomics Total Addressable Market (TAM)
6. Personalized Genomics Market Segmentation
6.1. Global Personalized Genomics Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oncology Testing
Infectious Disease Testing
Neurological Testing
Cardiovascular Testing
Other Test Types
6.2. Global Personalized Genomics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymerase Chain Reaction-Based Tests
Microarray-Based Tests
Sequencing-Based Tests
Other Technologies
6.3. Global Personalized Genomics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diagnostics
Precision Medicine
Wellness
Reproductive Health
Sports Nutrition And Health
Lifestyle
Other Applications
6.4. Global Personalized Genomics Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Research Centers
Pharmaceutical And Biotechnology Companies
Diagnostic Laboratories
Other End Users
6.5. Global Personalized Genomics Market, Sub-Segmentation Of Oncology Testing, By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Liquid Biopsy
Tumor Profiling
Genetic Testing for Cancer Risk
Companion Diagnostics
6.6. Global Personalized Genomics Market, Sub-Segmentation Of Infectious Disease Testing, By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hepatitis Testing
COVID-19 Testing
Respiratory Infections Testing
Sexually Transmitted Infections Testing
6.7. Global Personalized Genomics Market, Sub-Segmentation Of Neurological Testing, By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Alzheimer's Disease Testing
Huntington's Disease Testing
Parkinson's Disease Testing
Epilepsy Testing
6.8. Global Personalized Genomics Market, Sub-Segmentation Of Cardiovascular Testing, By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genetic Risk for Cardiovascular Diseases
Arrhythmia Testing
Lipid Panel Testing
Coronary Artery Disease Testing
6.9. Global Personalized Genomics Market, Sub-Segmentation Of Other Test Types, By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharmacogenomics Testing
Genetic Screening for Inherited Disorders
Paternity Testing
Ancestry Testing
7. Personalized Genomics Market Regional And Country Analysis
7.1. Global Personalized Genomics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Personalized Genomics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
